Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Part of paid clinical trials in Mission Hills, California.

Sponsor
Geriatric Oncology Consortium
Study ID
NCT00120172
Phase
PHASE2
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Currently there is no one standard of care for older patients with metastatic colorectal cancer. The study will examine the tumor response to capecitabine, oxaliplatin, plus bevacizumab. The study will also gather information on the usefulness and side effects of this treatment combination.

Key Dates

First listed
Jul 15, 2005
Start date
May 31, 2005
Status verified
Nov 2007
Completion
Jun 30, 2006

Study Design

Enrollment
40 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

To evaluate the efficacy (measured by time to progression) of oxaliplatin, capecitabine, and bevacizumab as first-line therapy in elderly patients with metastatic colorectal cancer.

Locations (5)

FacilityCityStateZIPSite coordinators
-Mission HillsCalifornia91345-
-Washington D.C.District of Columbia20007-
-InvernessFlorida34452-
-New Port RicheyFlorida34652-
-Coeur d'AleneIdaho83814-

Find similar trials in Mission Hills, CA

By condition
Colorectal cancer
By specialty
OncologyGI oncology

Related Studies